TATVA
Tatva Chintan Pharma Chem
Each stock's 10,000-path forecast, rendered as light.
Tatva Chintan Pharma Chem (TATVA) Stock Analysis & Case Study
Is TATVA a good buy? The data-driven verdict.
on the numbers it tread carefully, a Downstox Snapshot Score of 39/100.
On the numbers, Tatva Chintan Pharma Chem (TATVA) tread carefully, a Downstox Snapshot Score of 39/100, weighing a 44% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027–2031.
Last updated . Data snapshot for research, not investment advice.
TATVA share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 2.0y of TATVA history (3%/yr drift, 47%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| TATVA 2027 | ₹604 | ₹1,105 | ₹2,015 | -7% |
| TATVA 2028 | ₹438 | ₹1,016 | ₹2,371 | -15% |
| TATVA 2029 | ₹332 | ₹928 | ₹2,649 | -22% |
| TATVA 2030 | ₹262 | ₹853 | ₹2,881 | -29% |
| TATVA 2031 | ₹212 | ₹780 | ₹3,061 | -35% |
Median (P50) is the central estimate; the P10–P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability TATVA goes up, or doubles?
The bull case for TATVA
- Tatva Chintan Pharma Chem is part of the NSE universe with live, tracked fundamentals on Downstox.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹2,649.
The bear case & risks
- The probability model is cautious 12 months out, only a 44% chance of finishing above today's price.
- High historical volatility (47%/yr) means a wide, bumpy range of outcomes, size positions accordingly.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹332.
TATVA volatility & expected range, how bumpy is the ride?
Over the last 2.0 years TATVA compounded at 3%/year with annualized volatility of 47%. That volatility implies a 1-year 80% range of ₹604–₹2,015, the honest backbone behind any single price target.
TATVA price forecast, the full 60-month probability fan
TATVA price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds TATVA hits common targets within the simulated horizon?
Full multi-horizon detail on the TATVA price target & forecast page.
TATVA MTF margin & leverage, Upstox, Zerodha, Groww, Dhan
Margin Trading Facility lets you buy TATVA with part of the capital. Lower margin % = higher leverage. Rates compared across brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| UpstoxCHEAPEST | 37.0% | 2.7× |
| ZerodhaCHEAPEST | 37.0% | 2.7× |
| Dhan | 40.0% | 2.5× |
Compare every broker on the TATVA MTF page.
TATVA vs peers,sector comparison
About Tatva Chintan Pharma Chem: sector, index & market-cap context
Tatva Chintan Pharma Chem (TATVA) is an NSE-listed company.
How the TATVA Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of Tatva Chintan Pharma Chem's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
TATVA analysis, FAQs
Is Tatva Chintan Pharma Chem (TATVA) a good buy?
On the numbers, Tatva Chintan Pharma Chem (TATVA) tread carefully, a Downstox Snapshot Score of 39/100, weighing a 44% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is TATVA overvalued or undervalued?
Valuation ratios for TATVA are tracked live on Downstox.
What is the TATVA share price target for 2031?
TATVA's probability-weighted 2031 median target is ₹780, with an 80% range of ₹212–₹3,061 (10,000-path Monte-Carlo).
What is the probability TATVA doubles in 5 years?
The modelled probability of TATVA reaching ₹2,388 (2×) within 5 years is 15%.
What is the bull case for TATVA?
Tatva Chintan Pharma Chem is part of the NSE universe with live, tracked fundamentals on Downstox.
What are the risks in TATVA?
The probability model is cautious 12 months out, only a 44% chance of finishing above today's price. High historical volatility (47%/yr) means a wide, bumpy range of outcomes, size positions accordingly.